Entourage Health to Report Fiscal Year 2023 Financial Results
Entourage Health Corp. announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024.
Entourage Health Provides Corporate Update
Entourage Health Corp. Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, will step down to pursue other career opportunities, effective December 18, 2023.
Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue
Entourage Health Corp. announced today its financial results for the three and nine months ended September 30, 2023.
Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28
Entourage Health Corp. announced today it will file its third quarter 2023 financial statements and management’s discussion and analysis after-market on Monday, November 27, 2023.
Entourage Health Announces Amendment to Key Supply Agreement
Entourage Health Corp. announced it has entered into an amended supply agreement with HEXO Corp..
Entourage Health Reports Second Quarter 2023 Financial Results
Entourage Health Corp. announced today its financial results for the three months and six ended June 30, 2023.
Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis
Entourage unveils a wave of nostalgic Dime Bag® branded pre-roll offerings, now available in Ontario. Additionally, the Company introduces Syndicate-branded cannabis products, featuring exclusive limited-edition offerings from micro-cultivators now available across Ontario.
Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30
Entourage announced today it will file its second quarter 2023 financial statements and management’s discussion and analysis after market on Tuesday, August 29, 2023.
Entourage Health Announces First International Sale of Bulk Cannabis to Australia
Entourage announced today the successful sale, execution and fulfilment of its first international order of 100kg of bulk medical cannabis to Australia.
Entourage Health Announces Restructuring of Senior Secured Debt
Entourage announced today that the Company has partially repaid its senior secured credit facility with Bank of Montreal from the net proceeds of the sale of its Strathroy facility and cash.
Entourage Announces Results of 2023 Annual General Meeting of Shareholders
Entourage is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 14, 2023.
Entourage Health Reports First Quarter 2023 Financial Results
Entourage announced today its financial results for the three months ended March 31, 2023.
Entourage Health to Host First Quarter 2023 Earnings Conference Call
Entourage Health Corp. announced today that the Company's first quarter 2023 financial results will be released after market close on Monday, May 29, 2023.
Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues
Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.
Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results
Entourage Health Corp. announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2022, by Monday, May 1, 2023.
Entourage Health Announces Timing of Fiscal Year End 2022 Conference Call for April 28
Entourage Health Corp. announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2022, after market close on Thursday, April 27, 2023.
Entourage Health Corp Issues Deferred Share Units and Enters into Shares-for-Debt Agreements
Entourage Health Corp. announced today that, in accordance with the provisions of its omnibus equity incentive compensation plan, the Company has authorized the issuance of an aggregate of 1,600,000 deferred share units to non-management directors of the Company as compensation for their services.
Entourage Health Continues to Expand Medical Offerings with Launch of CBD Chewing Gum and Signs New Union Group to the Starseed Medicinal Program
Entourage Health Corp. is pleased to announce the expansion of its medical portfolio with the launch of a new CBD chewing gum available to Starseed patients on the Company’s medical platform.
Entourage Health Launches New Color Cannabis and Saturday Cannabis Products
Entourage Health Corp. is pleased to announce the expansion of its brand portfolio with new offerings.
Entourage Health and LiUNA Pension Fund Close on $15 Million of Previously Announced Debt Financing
Entourage Health Corp. is pleased to announce it has successfully closed the second $15 million tranche of its upsized credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, as announced on October 31, 2022.